The most important financial indicators for the company Psi Pharma Support Romania Srl - Unique Identification Number 15297440:
sales in 2023 was
8.336.922
euro, registering a net profit of
270.935
euro and having an average number of
126
employees.
Firma isi desfasoara activitatea in domeniul Cercetare-dezvoltare in alte stiinte naturale si inginerie having the NACE code 7219.
Sales, Profit, Employees, Debts, Capitals, Financial Results -
Psi Pharma Support Romania Srl
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Sales - EUR
6.544.359
7.789.111
6.417.760
7.112.939
5.489.447
5.620.762
6.468.653
6.788.707
8.095.461
8.336.922
Total Income - EUR
6.600.886
7.847.717
6.470.739
7.287.598
5.560.760
5.687.216
6.526.399
6.847.635
8.155.821
8.399.025
Total Expenses - EUR
6.507.487
7.778.922
6.407.643
7.098.428
5.497.036
5.616.965
6.367.150
6.538.510
7.859.948
8.064.187
Gross Profit/Loss - EUR
93.399
68.795
63.096
189.170
63.724
70.251
159.249
309.125
295.873
334.838
Net Profit/Loss - EUR
22.808
38.522
35.105
132.581
40.275
46.670
129.284
256.343
223.654
270.935
Employees
88
91
89
90
87
92
95
111
124
126
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded.
In the last year of activity, the sales increased by 3.3%, from 8.095.461 euro in the year 2022, to 8.336.922 euro in 2023.
The Net Profit increased by 47.959 euro, from 223.654 euro in 2022, to 270.935 in the last year.
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Psi Pharma Support Romania Srl - CUI 15297440
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Fixed Assets
194.730
172.500
135.887
7.177.083
7.053.523
6.706.511
6.321.449
5.997.493
5.831.863
5.644.077
Current Assets
947.641
890.743
1.109.782
1.269.453
785.720
1.001.849
1.112.508
1.453.846
1.833.697
1.774.935
Inventories
21.023
12.750
5.947
0
0
0
0
0
0
0
Receivables
913.585
870.070
1.067.901
1.173.285
658.516
835.358
817.711
1.021.490
1.118.489
907.802
Cash
13.033
7.922
35.934
96.168
127.204
166.491
294.796
432.356
715.208
867.133
Shareholders Funds
343.987
96.800
130.917
7.192.156
7.100.443
7.009.605
7.006.003
7.106.981
7.352.686
7.106.024
Social Capital
7.541
7.604
7.526
6.938.272
6.810.942
6.679.041
6.552.422
6.407.116
6.426.994
6.407.504
Debts
802.391
974.887
1.136.591
1.273.100
759.429
716.457
448.473
368.678
350.730
346.646
Income in Advance
21.023
12.750
5.947
0
0
0
0
0
0
0
Exchange rate - RON
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
4.4821
Main CAEN
"7219 - 7219"
CAEN Financial Year
7219
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
1.774.935 euro in 2023 which includes Inventories of
0 euro, Receivables of
907.802 euro and cash availability of
867.133 euro.
The company's Equity was valued at
7.106.024 euro, while total Liabilities amounted to
346.646 euro.
Equity decreased by -224.365 euro, from 7.352.686 euro in 2022, to 7.106.024 in 2023.
Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Psi Pharma Support Romania Srl